Xu D - Search Results

1

Attenuated bacteria as effectors in cancer immunotherapy.

Al-Ramadi BK, Fernandez-Cabezudo MJ, El-Hasasna H, Al-Salam S, Attoub S, Xu D, Chouaib S. Al-Ramadi BK, et al. Among authors: xu d. Ann N Y Acad Sci. 2008 Sep;1138:351-7. doi: 10.1196/annals.1414.036. Ann N Y Acad Sci. 2008. PMID: 18837910

2

Activation of innate immune responses by IL-2-expressing Salmonella typhimurium is independent of Toll-like receptor 4.

al-Ramadi BK, Fernandez-Cabezudo MJ, Mustafa N, Xu D. al-Ramadi BK, et al. Among authors: xu d. Mol Immunol. 2004 Jan;40(10):671-9. doi: 10.1016/j.molimm.2003.09.005. Mol Immunol. 2004. PMID: 14644093

3

Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha.

al-Ramadi BK, Al-Dhaheri MH, Mustafa N, Abouhaidar M, Xu D, Liew FY, Lukic ML, Fernandez-Cabezudo MJ. al-Ramadi BK, et al. Among authors: xu d. Infect Immun. 2001 Jun;69(6):3980-8. doi: 10.1128/IAI.69.6.3980-3988.2001. Infect Immun. 2001. PMID: 11349067 Free PMC article.

4

Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-beta genes.

Huggins ML, Huang FP, Xu D, Lindop G, Stott DI. Huggins ML, et al. Among authors: xu d. Ann N Y Acad Sci. 1997 Apr 5;815:499-502. doi: 10.1111/j.1749-6632.1997.tb52114.x. Ann N Y Acad Sci. 1997. PMID: 9186709 No abstract available.

5

The cytokine interleukin-33 mediates anaphylactic shock.

Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, McKenzie A, Liew FY, Melendez AJ. Pushparaj PN, et al. Among authors: xu d. Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9773-8. doi: 10.1073/pnas.0901206106. Epub 2009 Jun 8. Proc Natl Acad Sci U S A. 2009. Retraction in: Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13877. doi: 10.1073/pnas.1212463109 PMID: 19506243 Free PMC article. Retracted.

6

Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium.

Xu D, McSorley SJ, Tetley L, Chatfield S, Dougan G, Chan WL, Satoskar A, David JR, Liew FY. Xu D, et al. J Immunol. 1998 Feb 1;160(3):1285-9. J Immunol. 1998. PMID: 9570545

7

IL-33 exacerbates antigen-induced arthritis by activating mast cells.

Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie AN, McInnes IB, Liew FY. Xu D, et al. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10913-8. doi: 10.1073/pnas.0801898105. Epub 2008 Jul 30. Proc Natl Acad Sci U S A. 2008. PMID: 18667700 Free PMC article.

8

Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier.

Huggins ML, Huang FP, Xu D, Lindop G, Stott DI. Huggins ML, et al. Among authors: xu d. Lupus. 1999;8(1):29-38. doi: 10.1191/096120399678847308. Lupus. 1999. PMID: 10025597

9

Expression of TGF-beta in attenuated Salmonella typhimurium: oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice.

Ianaro A, Xu D, O'Donnell CA, Di Rosa M, Liew FY. Ianaro A, et al. Among authors: xu d. Immunology. 1995 Jan;84(1):8-15. Immunology. 1995. PMID: 7890306 Free PMC article.

10

Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-).

Xu D, McSorley SJ, Chatfield SN, Dougan G, Liew FY. Xu D, et al. Immunology. 1995 May;85(1):1-7. Immunology. 1995. PMID: 7635511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,849 results

Search Page

Filters